$2.470
-0.105 (-4.26%)Al cierre
Predicciones de precio
Ábrelo en la app para desbloquear previsiones a más largo plazo.
Predicción y previsión de XTLB por análisis de gráficos similares
Alphio's XTLB stock price prediction model matches the current X T L Biopharmaceuticals Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $2.49 (+1.01%). The 1-week path is $2.50 (+1.05%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
¿Debería comprar acciones de X T L Biopharmaceuticals Ltd?
XTL Biopharmaceuticals Ltd is not a good buy right now due to its current price of $2.47 and a concerning RSI of 30.106, indicating oversold conditions. The company is facing serious risks, including a Nasdaq compliance notice for failing to meet minimum shareholder equity requirements, which could lead to delisting. Additionally, the stock has experienced a 48.11% decline over the past year, reflecting ongoing financial instability.
XTLB cerró en $2.47 el Friday, tras bajar -4.26%
X T L Biopharmaceuticals Ltd (XTLB) last closed at $2.47, losing -4.26%. These facts feed the 1-day and 1-week XTLB price prediction above.
Factores de la previsión
Los factores de la previsión de X T L Biopharmaceuticals Ltd (XTLB) combinan patrones gráficos similares, estacionalidad y medias móviles.
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
Patrones gráficos similares
Acciones cuya trayectoria reciente más se parece a la de XTLB, ordenadas por similitud.
Análisis de estacionalidad de XTLB
Historically the probability of a positive August return for XTLB is 66.67%. July offers the highest probability of a positive month at 66.67%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
Proyecciones de precio a 10 años de XTLB
| Mes | Precio mínimo | Precio medio | Precio máximo | ROI potencial |
|---|---|---|---|---|
| Aug 2026 | $1.81 | $1.97 | $2.04 | -20.06% |
| Sep 2026 | $1.53 | $1.57 | $1.73 | -36.40% |
| Oct 2026 | $1.26 | $1.59 | $1.85 | -35.65% |
| Nov 2026 | $1.86 | $1.91 | $2.28 | -22.53% |
| Dec 2026 | $2.08 | $2.09 | $2.34 | -15.48% |
En 2026, se proyecta que X T L Biopharmaceuticals Ltd (XTLB) oscile entre $1.26 y $2.34.
Previsión mensual de X T L Biopharmaceuticals Ltd para 2026
En Aug de 2026, se proyecta que X T L Biopharmaceuticals Ltd promedie $1.97, con un mínimo de $1.81 y un máximo de $2.04.
En Sep de 2026, se proyecta que X T L Biopharmaceuticals Ltd promedie $1.57, con un mínimo de $1.53 y un máximo de $1.73.
En Oct de 2026, se proyecta que X T L Biopharmaceuticals Ltd promedie $1.59, con un mínimo de $1.26 y un máximo de $1.85.
En Nov de 2026, se proyecta que X T L Biopharmaceuticals Ltd promedie $1.91, con un mínimo de $1.86 y un máximo de $2.28.
En Dec de 2026, se proyecta que X T L Biopharmaceuticals Ltd promedie $2.09, con un mínimo de $2.08 y un máximo de $2.34.
Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.